NR3C1 and colorectal adenocarcinoma: Importantly, analysis of GR expression in cohorts of patients with colorectal adenocarcinoma, superficial bladder cancer, ovarian serous cystadenocarcinoma and squamous cell lung carcinoma also revealed that increased GR expression was associated with poor prognosis (Supplementary Fig. 2).